Karma Holistic Centers, Inc – Trademark Portfolio
Entity Type: 03
Karma Holistic Centers, Inc holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include HEPACTN, LIPOTHN, and CLUSTER ANTIPYRETIC. The owner is based in Los Angeles,, CA.
5871 Compass Drive,
5871 compass dr
Los Angeles,, CA 90045
Showing of trademarks Trademarks
Trademark Classifications
Karma Holistic Centers, Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Karma Holistic Centers, Inc have?
Karma Holistic Centers, Inc has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending.
What trademark classes does Karma Holistic Centers, Inc file in?
Karma Holistic Centers, Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Karma Holistic Centers, Inc's most well-known trademarks?
Karma Holistic Centers, Inc's registered trademark portfolio includes well-known marks such as HEPACTN, LIPOTHN, and CLUSTER ANTIPYRETIC. These are among 3 currently registered trademarks in the portfolio.
What is Karma Holistic Centers, Inc's trademark registration success rate?
Karma Holistic Centers, Inc has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.